Sunday, March 22, 2015 12:24:53 PM
Now, if I were holding out for just one drug, then, I would agree, it may not go up. But, that is not the case on this one. 3 drugs, one in development, one in phase 3, and, one FDA approved for the U.S. SO, this isn't a one hit wonder.
What we have here is a GENE Biotech, which, isn't even your typical BIO tech to start with. GENE research has *many* applications from STEM CELL to CANCER. I included a direct link to a 78 page introduction / presentation on the company, in a previous post. And, they are being invited to present a conferences across the country, regarding their current phase 3 trial.
BOOMTOWN
Where The Whales Shop!
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM